August 11, 2022
UAMS Researcher Co-Authors Nature Communications Article Showing Higher Heart Failure Rates in Some COVID-19 Patients

LITTLE ROCK — Patients previously hospitalized with COVID-19 had a 45% higher risk of heart failure than other hospitalized patients, according to the first national study of its kind, which was co-authored by a University of Arkansas for Medical Sciences (UAMS) researcher. Lead author Husam M. Salah, M.D., at UAMS said the findings reported in…
August 4, 2022
Community Finds Fun, Health Information at UAMS Midsouth Black Expo

With high school band music and cheerful chatter as a backdrop, Marcovous Williams got some sobering news about her health. A health check at one of the 80 vendor booths at the UA MS Midsouth Black Expo revealed that she had high blood pressure. “I came to get more information about my health,” said Williams,…
July 19, 2022
UAMS Researchers Publish Advances in Use of Noninvasive, Miniature Laser-Based Blood Scanner for Disease Identification

A University of Arkansas for Medical Sciences (UAMS) research team has published new advances in its ability to detect cancer, infections and other medical conditions using a portable blood sensor that does not require needles or other invasive methods. Scientific Reports, a Nature Portfolio journal, published the work led by UAMS’ Vladimir Zharov, Ph.D., D.Sc.,…
June 28, 2022
NIH Funds UAMS Study Testing Rapid Genomic Surveillance for Antibiotic Resistant Infections

A University of Arkansas for Medical Sciences (UAMS) study is developing real-time and accurate genomic methods that can be used routinely to deliver life-saving information to doctors treating antibiotic-resistant infections. Backed by a two-year, $418,000 National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) grant, UAMS’ Se-Ran Jun, Ph.D., says the…
June 27, 2022
UAMS’ Eric Peterson, Ph.D., Named Executive Vice President of BioVentures LLC

LITTLE ROCK — Eric Peterson, Ph.D., has been named executive vice president of BioVentures LLC at the University of Arkansas for Medical Sciences (UAMS). Peterson is chair of the UAMS Patent and Copyright Committee and is an associate professor in the College of Medicine Department of Pharmacology and Toxicology. As executive vice president, he will…
June 7, 2022
UAMS, CAVHS Studying Health Effects of Arkansas Veterans’ Exposure to Burn Pits in Middle East

LITTLE ROCK — More than 300 Arkansas veterans will become part of a new study conducted by the University of Arkansas for Medical Sciences (UAMS) and the Central Arkansas Veterans Healthcare System (CAVHS) to determine if exposure to open pit burning and molecular-level changes are associated with chronic health conditions. The Department of Veterans Affairs…
June 2, 2022
UAMS Study First to Test When Common Arsenic Exposures Are Most Likely to Cause Male Infertility in Offspring

LITTLE ROCK — In the first study of its kind, researchers at the University of Arkansas for Medical Sciences (UAMS) will test when exposure to inorganic arsenic — a common, harmful environmental toxin — is most likely to lead to infertility traits that may last for generations. The study, supported by a five-year, $2.54 million…
May 31, 2022
TRI Announces Nine KL2 Scholars for 2022-2023

The UAMS Translational Research Institute’s KL2 Mentored Research Career Development Scholars Program announced nine new scholars for 2022-2023, its largest-ever class. These promising early-career researchers receive two years of funded support and mentored translational research training. The program selects scholars through a competitive application process and provides 75% salary support and up to $25,000 a…
May 26, 2022
Four UAMS Faculty Receive 2022 Provost’s Innovator Awards

The University of Arkansas for Medical Sciences (UAMS) announced four UAMS faculty as recipients of the Provost’s Innovator Awards. The awards were established by Stephanie Gardner, Pharm.D., Ed.D., UAMS provost and chief strategy officer, and Shuk-Mei Ho, Ph.D., vice chancellor for Research and Innovation. The grants of $25,000 each support groundbreaking, innovative, high-impact projects that…
May 23, 2022
UAMS Begins Final Study of First Rapid Test for Acetaminophen Toxicity with $3.2 Million Grant

The first rapid diagnostic test for acetaminophen toxicity has cleared a major hurdle on its long road to the marketplace from UAMS.
Next page